Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial
Phillips, EH Devereux, S Radford, John A Mir, N Adedayo, T Clifton-Hadley, L Johnson, R
Phillips, EH
Devereux, S
Radford, John A
Mir, N
Adedayo, T
Clifton-Hadley, L
Johnson, R
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Phillips EH, Devereux S, Radford J, Mir N, Adedayo T, Clifton-Hadley L, et al. Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial. Leuk Lymphoma. 2019 Feb 18:1-4.